- The Asia-Pacific Dry Eye Syndrome Treatment Market is anticipated to experience robust growth during the forecast period, with a CAGR of 9.1% from 2025 to 2032.
- Dry Eye Syndrome (DES), also known as keratoconjunctivitis sicca, is a multifactorial disease affecting the tear film and ocular surface, commonly caused by meibomian gland dysfunction, environmental factors, and systemic medications.
- The market is being driven by a rising demand for preservative-free artificial tears, development of novel anti-inflammatory eye drops, and incorporation of regenerative medicine such as autologous serum-based treatments.
- Factors such as increasing healthcare infrastructure, improved accessibility to specialized eye care, and a rise in awareness campaigns across emerging countries like India, China, and Southeast Asia are expected to support market expansion
